Capricor Therapeutics Inc (CAPR)
Healthcare
Biotechnology
3.90 $
-8.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Capricor Therapeutics Inc (CAPR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -29 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.4 | -8.8 | -12 | -1.3 | -12 | -12 | -15 | -6.4 | -20 | -20 | -24 | -29 | -93 | |
| 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 247 | 1,003 | 0.5 | 1,251 | |
| 1.6 | 1.7 | 1.9 | 3.3 | 2.2 | 2.1 | 2.3 | 5.7 | 3.6 | 7,369 | -3,394 | 5.9 | 3,985 | |
| 1.6 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -3.9 | -4.4 | -13 | 4.9 | -3.8 | -1.2 | -10 | 12 | 1.7 | 0.0 | -1.2 | -2.0 | -1.5 | |
| 0.2 | 0.6 | 0.7 | 0.7 | 0.1 | 0.1 | 0.7 | 1.1 | 1.4 | 4.0 | 5.1 | 11 | 21 | |
| 6.5 | 7.7 | -5.9 | -9.5 | 15 | 2.0 | -123 | 24 | 15 | 16 | 43 | -155 | -81 | |
| 2.2 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.2 | 0.2 | 23 | 2.3 | 2.1 | 67 | 81 | 0.1 | 0.0 | 0.0 | 249 | 1.5 | 250 | |
| -0.8 | -0.9 | 5.7 | -8.5 | 4.5 | 58 | -57 | 18 | -5.6 | -3.7 | 268 | -182 | 77 | |
| -9.7 | -9.4 | -12 | -1.9 | -12 | -12 | -16 | -7.6 | -22 | -24 | -29 | -40 | -114 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.